R.M. Hagan

Investigation into species variants in tachykinin NK₁ receptors by use of the non‐peptide antagonist, CP‐96,345

I.J.M. Beresford, P.J. Birch, R.M. Hagan et al. · British Journal of Pharmacology · 1991 · 220 citations · Full text

Medicine, Pharmacology, Comparative Pharmacology +13

Potent and highly selective neurokinin antagonists

P. Ward, George B. Ewan, Christopher Jordan et al. · Journal of Medicinal Chemistry · 1990 · 158 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: New tools for investigating neurokinin function

R.M. Hagan, S.J. Ireland, Christopher Jordan et al. · Neuropeptides · 1991 · 108 citations

Medicine, Neuroscience, Pharmacology +14

Effect of 5‐HT₃ receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat

R.M. Hagan, Brian J. Jones, Christopher Jordan et al. · British Journal of Pharmacology · 1990 · 108 citations · Full text

Medicine, Neuroscience, Pharmacology +17

The pharmacology of GR203040, a novel, potent and selective non‐peptide tachykinin NK₁ receptor antagonist

David T. Beattie, I.J.M. Beresford, Helen E. Connor et al. · British Journal of Pharmacology · 1995 · 80 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12